| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |